患者特征与干预措施的一致性可能部分解释药物依从性干预效果:一项基于Cochrane系统评价190项随机对照试验的分析
该分析基于Cochrane系统评价数据库中的190项随机对照试验,构建了包含六个特征的一致性评分,由两名独立评价者提取并评分。结果显示仅“纳入不依从患者”这一特征与有效依从性干预显著相关(P=0.003),而总体一致性评分及其他特征均无显著关联;有效依从性干预与临床结局改善显著相关(OR=6.0,95%CI=3.1-12.0,P<0.0001)。
要点
- 纳入不依从患者是唯一与有效依从性干预显著相关的特征(P=0.003)。
- 有效依从性干预与临床结局改善显著相关(OR=6.0,95%CI=3.1-12.0)。
- 总体一致性评分及其他五个特征与干预效果无显著关联。
核心结论
- 仅六项研究纳入了不依从患者,且该特征与其余五个特征相互依赖,可能妨碍对患者特征与依从性干预一致性的结论性评估;为从有效依从性干预中获得临床获益,作者鼓励研究者关注纳入不依从患者。
研究设计与样本
- 基于Cochrane系统评价数据库中的190项随机对照试验,构建包含六个特征的一致性评分,由两名独立评价者提取并评分。
主要发现
- 新提取数据的评价者间信度几乎完美,Cohen's Kappa为0.92(95%CI=0.89-0.94,P<0.001)。
- 纳入不依从患者仅见于六项研究,是唯一与有效依从性干预显著相关的特征(P=0.003)。
- 有效依从性干预与临床结局改善显著相关(OR=6.0,95%CI=3.1-12.0,P<0.0001)。
- 总体一致性评分及其他五个特征(不依从决定因素作为纳入标准、干预措施针对纳入标准定制、基线评估不依从原因、干预调整至患者个体需求、基于理论的干预)均与干预效果无显著关联。
临床怎么用
- 作者鼓励研究者关注纳入不依从患者,以从有效依从性干预中获得临床获益。
局限性
- 仅六项研究纳入了不依从患者。
- 该特征与其余五个特征相互依赖,可能妨碍结论性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Due to the negative outcomes of medication nonadherence, interventions to improve adherence have been the focus of countless studies. The congruence between adherence-related patient characteristics and interventions may partly explain the variability of effectiveness in medication adherence studies. In their latest update of a Cochrane review reporting inconsistent effects of adherence interventions, the authors offered access to their database for subanalysis. We aimed to use this database to assess congruence between adherence-related patient characteristics and interventions and its association with intervention effects. STUDY DESIGN AND SETTING: We developed a congruence score consisting of six features related to inclusion criteria, patient characteristics at baseline, and intervention design. Two independent raters extracted and scored items from the 190 studies available in the Cochrane database. We correlated overall congruence score and individual features with intervention effects regarding adherence and clinical outcomes using Kruskal-Wallis rank sum test and Fisher's exact test. RESULTS: Interrater reliability for newly extracted data was almost perfect with a Cohen's Kappa of 0.92 [95% confidence interval (CI) = 0.89-0.94; P < 0.001]. Although present in only six studies, the inclusion of nonadherent patients was the single feature significantly associated with effective adherence interventions (P = 0.003). Moreover, effective adherence interventions were significantly associated with improved clinical outcomes (odds ratio = 6.0; 95% CI = 3.1-12.0; P < 0.0001). However, neither the overall congruence score nor any other individual feature (i.e., "determinants of nonadherence as inclusion criteria," "tailoring of interventions to the inclusion criteria," "reasons for nonadherence assessed at baseline," "adjustment of intervention to individual patient needs," and "theory-based interventions") was significantly associated with intervention effects. CONCLUSION: The presence of only six studies that included nonadherent patients and the interdependency of this feature with the remaining five might preclude a conclusive assessment of congruence between patient characteristics and adherence interventions. In order to obtain clinical benefits from effective adherence interventions, we encourage researchers to focus on the inclusion of nonadherent patients.
引用
- Allemann SS, Nieuwlaat R, Navarro T, et al. Congruence between patient characteristics and interventions may partly explain medication adherence intervention effectiveness: an analysis of 190 randomized controlled trials from a Cochrane systematic review. J Clin Epidemiol. 2017. PMID: 28802672. doi:10.1016/j.jclinepi.2017.07.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。